Lesson plan
Refaat El-Sayed
Refaat El-Sayed (born 11 February 1946 in Egypt) is a businessman of Egyptian and Swedish nationality. In 1981, he took command of a small biotech company, Fermenta, which he quickly turned into one of the success stories of the Stockholm stock exchange. El-Sayed soon became Sweden's wealthiest man, and created a fortune for his employees and shareholders. In December 1985 he was named "Swede of the year" by the TV news program Rapport. The following month, Fermenta announced a partnership with Swedish industrial giant Volvo. El-Sayed was at the peak of his fame. In February 1986, El-Sayed was accused of lying about his academic qualifications, as he had falsely asserted he was a Doctor of Science in biochemistry from a university in the United States. The partnership with Volvo was broken. He was later sentenced to six years in prison for fraud. In 1992, El-Sayed became the CEO of another biotech company, Hebi Health Care. El-Sayed has not been accused or indicted for any acts of creative accounting or fraud. However, he has been charged with misconduct for allegedly showing a higher profit of US$5 million out of a total turnover of US$600 million. El-Sayed was the first person charged in Sweden under the law from 1927. In 2002 a judgment against El-Sayed for fraud was canceled.
Article summary
Refaat El-Sayed (born 11 February 1946 in Egypt) is a businessman of Egyptian and Swedish nationality. In 1981, he took command of a small biotech company, Fermenta, which he quickly turned into one of the success stories of the Stockholm stock exchange. El-Sayed soon became Sweden's wealthiest man, and created a fortune for his employees and shareholders. In December 1985 he was named "Swede of the year" by the TV news program Rapport. The following month, Fermenta announced a partnership with Swedish industrial giant Volvo. El-Sayed was at the peak of his fame. In February 1986, El-Sayed was accused of lying about his academic qualifications, as he had falsely asserted he was a Doctor of Science in biochemistry from a university in the United States. The partnership with Volvo was broken. He was later sentenced to six years in prison for fraud. In 1992, El-Sayed became the CEO of another biotech company, Hebi Health Care. El-Sayed has not been accused or indicted for any acts of creative accounting or fraud. However, he has been charged with misconduct for allegedly showing a higher profit of US$5 million out of a total turnover of US$600 million. El-Sayed was the first person charged in Sweden under the law from 1927. In 2002 a judgment against El-Sayed for fraud was canceled.
Key claims
- date of birth: 1946-02-11 — source: Wikipedia, revision 1377226879, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the date of birth is "1946-02-11". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.